09/28/21 | CMS gives more insight into appropriate DOS for imaging
 

The Center for Medicare and Medicaid Services (CMS) has guidance for reporting the date of service (DOS) for various services. Information provided for global reporting, technical reporting and professional reporting

 

CMS gives more insight into appropriate DOS for imaging
 
07/01/21 | New CPT code for Subchondroplasty
 

Effective July 1st 2021 - the AMA released a new code for Subchondroplasties - are you ready for it

New CPT code for Subchondroplasty
 
03/17/20 | Telehealth regulations loosened
 

With the Coronavirus issues CMS has loosened the regulations and HIPAA issues that have caused concerns about when telehealth can be used. Check out the new release

Telehealth regulations loosened
 
01/29/20 | New Drug Delivery Codes 20700-20705
 

Stop using 11981-11983 as of Jan 1st 2020- Use the new drug delivery codes 20700-20705 --

New Drug Delivery Codes 20700-20705
 
04/04/19 | Watch your "stem cell" wording - On going FBI investigations
 

For those offices that are using the wording 'stem cells' or charging patients for these services you need to be aware of the FBI ongoing investigations.

Watch your
 
02/28/19 | Great article on the issues with 63047 and 22633 and 22630
 

Find out about the issues between 22633/22630 and 63047 and get the history of these codes.  Great information you can use for your private payer appeals.

Great article on the issues with 63047 and 22633 and 22630
 
01/02/19 | Accessing Newsletters
 

How to get newsletters

Accessing Newsletters
 
01/02/19 | Calendar events
 

Calendar events

Calendar events
 
Archive - See All Entries

If your physician has been thinking about getting into "physician-owned distributorships" you might want to take heed to the new advisory opinion from the OIG.

In this special alert it states: "The Office of Inspector General (OIG) has issued a number of guidance documents on the general subject of physician investments in entities to which they refer, including the 1989 Special Fraud Alert on Joint Venture Arrangements and various other publications. OIG also provided guidance specifically addressing physician investments in medical device manufacturers and distributors in an October 6, 2006 letter. In that letter, we noted "the strong potential for improper inducements between and among the physician investors, the entities, device vendors, and device purchasers" and stated that such ventures "should be closely scrutinized under the fraud and abuse laws." This Special Fraud Alert focuses on the specific attributes and practices of PODs that we believe produce substantial fraud and abuse risk and pose dangers to patient safety."

https://oig.hhs.gov/fraud/docs/alertsandbulletins/2013/POD_Special_Fraud_Alert.pdf